XML 205 R58.htm IDEA: XBRL DOCUMENT v3.26.1
Sale of RPK - Schedule of Consolidated Statements of Loss and Comprehensive Loss (Details) - Bophelo Bio Science and Wellness (Pty) Ltd. ("Bophelo") - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Dec. 31, 2022
Schedule of Consolidated Statements of Loss and Comprehensive Loss [Line Items]      
Cash received $ 2,000,000 $ 2,000,000  
Finder’s fee – transaction cost (446,250) (446,250)  
Consideration received, net 1,553,750 1,553,750  
Cash 105,175 105,175 $ 739,947
Accounts receivable (note 6) 158,812 158,812  
Inventory (note 7) 895,715 895,715  
Prepayments 33,762 33,762  
Property, plant and equipment, net (note 9) 1,769,221 1,769,221  
Intangible licenses (note 11) 3,783,117 3,783,117  
Accounts payable (2,016,744) (2,016,744)  
Bank loans (note 14) (3,374,088) (3,374,088)  
Net assets sold 1,354,970 1,354,970  
Gain on sale of subsidiary $ 198,780 $ 198,780 $ 2,085,624